Composed of β-TCP, CaCO3, silicon, and PLGA, the special formula contains 0.5% to 1% silicon by weight, which is comparable to the level found in natural bone.
The interconnected network of microporous fibers in BioCera Fibers is created by a unique and proprietary electrospinning process that produces an absorbent, biodegradable scaffold. BioCera Fibers is known for its moldable properties, as well
as for its ability to retain bioactive fluids, which enhances its osteoinductive potential.
Biocera Explainer Video
- Proven to support cell activation, retention, and proliferation
- Superior handling characteristics
- Optimal fit and fill:
- BioCera Fibers offers up to 54% compression recovery
- Maintains integrity during and after placement
QDS developed to simplify hydration and insertion, allowing for controlled, accurate placement every time.
The BioCera Fibers Quick Delivery System (QDS) allows for controlled, accurate placement of our biosynthetic bone scaffold, ensuring that the material is perfectly placed, every time. The BioCera Fibers QDS was developed to simplify hydration and insertion, making it even easier to implant the only biosynthetic scaffold with electrospun microfiber construction. Slender, elongated syringe designed to access hard-to-reach areas (8 mm outside diameter, 134 mm in length).
Pre-filled syringe allows for ease of hydration and controlled delivery of BioCera Fibers Transparent tube allows product visualization and precise product placement.
KYOCERA Medical is committed to providing high quality orthopedic products that help surgeons meet the unique demands of every patient.
FIND US
HEADQUARTERS / WAREHOUSE
1289 Bryn Mawr Ave., Suite A.,
Redlands, CA 92374
R&D CENTER
10431 Morado Circle, Building V, Suite 150
Austin, TX 78759
©2025 Kyocera Medical Technologies, Inc. All rights reserved.